Niklas Mattsson
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 157 publications
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias.
Journal: Nature aging
Published: January 05, 2026
General anesthesia in early childhood and possible association with autism: a population-based matched cohort study.
Journal: Minerva anestesiologica
Published: October 25, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
Journal: JAMA neurology
Published: January 31, 2022
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Journal: The Lancet. Neurology
Published: February 05, 2020
Acute reduction of cerebrospinal fluid volume prior to spinal anesthesia: implications for sensory block extent.
Journal: Minerva anestesiologica
Published: February 05, 2020
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
Journal: Alzheimer's research & therapy
Published: November 08, 2019
Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1-42), pTau and tTau CSF immunoassays.
Journal: Scientific reports
Published: August 29, 2019
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
Journal: Nature medicine
Published: July 20, 2019
Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography.
Journal: JAMA neurology
Published: July 18, 2019
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.
Journal: EMBO molecular medicine
Published: July 16, 2019
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease.
Journal: Acta neuropathologica communications
Published: July 15, 2019
Primary fatty amides are potential plasma biomarkers for AD.
Journal: Nature reviews. Neurology
Published: June 30, 2019
Last Updated: 09/26/2026